Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

O

OTLK

Outlook Therapeutics Inc

0.4730

Nov 02 • 8:35 AM ET +0.0049 (1.05%)

Healthcare Biotechnology USA Micro NASD

Peers: EYPT OCUL KLRS KOD OCS LENZ ANNX IRD ALDX AURA

| Held by: VTI VXF

Scroll to Statements

Index	-
Market Cap	115.15M
Enterprise Value	122.34M
Income	-
Sales	-
Book/sh	-0.06
Cash/sh	0.05
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	17
IPO	Jun 14, 2016

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	10.24
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.63
Current Ratio	0.81
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-
EPS next Y	-0.18
EPS next Q	-0.07
EPS this Y	73.18%
EPS next Y	63.02%
EPS next 5Y	-
EPS past 3/5Y	33.96% 33.18%
Sales past 3/5Y	- -
EPS Y/Y TTM	86.28%
Sales Y/Y TTM	-
EPS Q/Q	90.10%
Sales Q/Q	-
Earnings	Aug 14 BMO
EPS/Sales Surpr.	-12.50% -99.07%

Insider Own	12.64%
Insider Trans	61.77%
Inst Own	27.22%
Inst Trans	20.42%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-10.85%
SMA50	-20.69%
SMA200	-28.60%
Trades

Shs Outstand	243.45M
Shs Float	212.68M
Short Float	15.32%
Short Ratio	3.21
Short Interest	32.59M
52W High	2.54 -81.36%
52W Low	0.16 193.61%
Volatility	8.51% 9.35%
ATR (14)	0.05
RSI (14)	36.94
Beta	0.76
Rel Volume	0.10
Avg Volume	10.17M
Volume	50,239

Perf Week	-7.85%
Perf Month	-20.24%
Perf Quarter	-50.74%
Perf Half Y	80.19%
Perf YTD	-70.06%
Perf Year	-62.46%
Perf 3Y	-93.04%
Perf 5Y	-98.87%
Perf 10Y	-99.93%
Recom	1.50
Target Price	5.03
Prev Close	0.47
Price	0.47
Change %	1.05%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)